Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium + cholecalciferol + menaquinone-7 (Eurogenerics)
- Development stage
- Unknown
- Lead developer
- Euro Vital Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calcium EG MAX is a dietary supplement developed by Euro Generics (EG) to support bone health and assist in the prevention of osteoporosis. The product features a combination of three key nutrients: elemental calcium (1000 mg), vitamin D3 (1000 IU/cholecalciferol), and vitamin K2 (75 µg/menaquinone-7). Calcium provides the essential mineral matrix for bone structure. Vitamin D3 promotes the intestinal absorption of calcium and maintains adequate serum calcium concentrations for bone mineralization. Vitamin K2 acts as a cofactor for the gamma-carboxylation of osteocalcin, a protein produced by osteoblasts that binds calcium to the bone matrix. This synergistic combination is intended for adults, particularly those with increased requirements such as the elderly or women during menopause, to maintain normal bone density and muscle function.
- Brand names
- Calcium EG MAX
- Other names
- calcium + vitamin D3 + vitamin K2
02
Targets
GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on calcium + cholecalciferol + menaquinone-7 (Eurogenerics).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium + cholecalciferol + menaquinone-7 (Eurogenerics).